Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: A pilot, randomized, double-blind, placebo-controlled trial

Journal of Psychiatric Practice

Volumn 12, Issue 2, 2006, Pages 103-108

  Veser, Frederick H ^a,d   Veser, Belynda Dunn ^a   McMullan, Jason T ^b   Zealberg, Joseph ^a   Currier, Glenn W ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d NONE   (United States)

Author keywords

Antipsychotic agents; Behavioral emergencies; Emergency medicine; Emergency services; Psychomotor agitation; Psychotic disorders

Indexed keywords

HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE; ANXIOLYTIC AGENT;

ACUTE DISEASE; ADULT; AGED; AGITATION; ANALYSIS OF VARIANCE; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HUMAN; KRUSKAL WALLIS TEST; MALE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM; TABLET; ADOLESCENT; DRUG ADMINISTRATION; DRUG COMBINATION; HOSPITALIZATION; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; RISPERIDONE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33745613574     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131746-200603000-00005     Document Type: Article

References (15)

1. Simini B. Patients' perceptions of pain with spinal, intramuscular, and venous injections. Lancet 2000;355:1076.
2. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001;62:153-7.
3. Federal Drug Administration. FDA strengthens warnings for droperidol (available at www.fda.gov/bbs/topics/ANSWERS/2001/ANS01123.html).
4. Currier GW, Chou JC, Feifel D, et al. Acute treatment of psychotic agitation: A randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry 2004;65:386-94.
5. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:97-9.
6. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
7. Brook S, Lucey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone IM Study Group. J Clin Psychiatry 2000,61:933-41.
8. Breier A, Meehan K, Birkett M, et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002,59:441-8.
9. Wright P, Birkett M, David SR, et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 2001,158:1149-51.
10. Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D Novel therapies for treating acute agitation. J Emerg Med 2004;27(4 Suppl):S13-8.
11. McCarthy EA. Resolution of the psychiatric emergency in the emergency department. Psychiatr Clin North Am 1983,6:281-92.
12. Sulkowicz KJ. Psychodynamic issues in the emergency department. Psychiatr Clin North Am 1999;22:911-22.
13. Borison RL, Pathiraja AP, Diamond BI et al. Risperidone: Clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 1992;28:213-8.
14. Clinical Pharmacology 2000, Gold Standard Multimedia, licensed by Harrison's Principles of Internal Medicine, 15th edition, On-Line Version. http://www.harrisonsonline.com. Accessed 29 January 2003. McGraw-Hill Companies.
15. Ereshefsky L, Tran-Johnson TK, Watanabe MD. Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics. Clin Pharm 1990;9:682-707.